Current NDC auxiliary source row outsourcing:2021-2:1663

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: outsourcing_history
Product Ndc Raw: 71266-2001
Product Ndc: 71266-2001
Product Ndc Digits: 712662001
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: [empty]
Proprietary Name Suffix: [empty]
Nonproprietary Name: Succinylcholine Chloride
Dosage Form Name: injection
Route Name: [empty]
Marketing Category Name: OUTSOURCING FACILITY PRODUCT REPORT
Labeler Name: Fagron Compounding Services LLC dba Fagron Sterile Services LLC(079977249)
Establishment Name: Fagron Compounding Services LLC dba Fagron Sterile Services LLC
Establishment Fei: 079977249
Substance Name: Succinylcholine Chloride
Active Ingredients Info: 20 mg/1 mL
History Active Ingredients Raw: Succinylcholine Chloride
History Active Ingredients Info Raw: 20 mg/1 mL
History Dosage Raw: injection
Dea Schedule: [empty]
Package Ndc Raw: 71266-2001-3
Package Ndc: 71266-2001-3
Package Ndc Digits: 7126620013
Package Ndc11: 71266200103
Package Description: 7 Ml in 1 Syringe (71266-2001-3)
Reporting Period Raw: 2021-2
Reporting Period: 2021-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/scripts/cder/outsourcingfacility/dsp_searchresult.cfm
Source Archive: outsourcing_2021-2.html
Source File: outsourcing_2021-2.html
Source Date: 2026-10-22
Source Last Modified: [null]
Source Archive Sha256: 8ed0d0581aa98971aceddb363b565d7e2ba84c67406acd8a43eb3e4cf4cde9c8
Source Member Sha256: 8ed0d0581aa98971aceddb363b565d7e2ba84c67406acd8a43eb3e4cf4cde9c8
Source Record Id: outsourcing:2021-2:1663
Source Row Number: 1663
Source Row Hash: bcab4050c09ba00c51fd2255dfb2687dab111ec786c5c6cadb757faf45982780
Import Run Id: 20261022T045816Z
Loaded At: 2026-10-22 05:03:38

Exact raw FDA source fields#

{
    "Dosage": "injection",
    "Estab. Name": "Fagron Compounding Services LLC dba Fagron Sterile Services LLC(079977249)",
    "Report Year": "2021-2",
    "NDC Package Code": "71266-2001-3",
    "Active Ingredients": "Succinylcholine Chloride",
    "Package Description": "7 Ml in 1 Syringe (71266-2001-3)",
    "Active Ingredients Info": "20 mg/1 mL"
}

Normalization notes#

[]

Parsed response revision#

Parsed source response revision for 2021-2

Current status projection#

Dataset: compounder
Record Source: outsourcing_history
Source Record Id: outsourcing:2021-2:1663
Source Row Number: 1663
Status Scope: package
Lookup Ndc: 71266-2001-3
Lookup Ndc Digits: 7126620013
Product Ndc: 71266-2001
Product Ndc Digits: 712662001
Package Ndc: 71266-2001-3
Package Ndc Digits: 7126620013
Package Ndc11: 71266200103
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2021-2
Reporting Period: 2021-2
Source Table: fda_ndc_aux_compounder
Source File: outsourcing_2021-2.html
Source Date: 2026-10-22
Source Row Hash: bcab4050c09ba00c51fd2255dfb2687dab111ec786c5c6cadb757faf45982780
Import Run Id: 20261022T045816Z
Loaded At: 2026-10-22 05:03:38